Policy # Policy Title Print View
VP-0043 Faslodex® (fulvestrant) (Intramuscular)
VP-0209 Keytruda® (pembrolizumab) (Intravenous)
VP-0482 Polivy™ (polatuzumab vedotin-piiq) (Intravenous)
VP-0483 Kanjinti™ (trastuzumab-anns) (Intravenous)
VP-0484 Zirabev™ (bevacizumab-bvzr) (Intravenous)
VP-0486 Ruxience® (rituximab-pvvr)